Honey for managing oral mucositis induced by cancer therapies: An overview of systematic reviews

IF 3.3 3区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
Huda Anshasi , Bassema Abufarsakh , Ja’far M. Alkhawaldeh , Sura Al Halalmeh
{"title":"Honey for managing oral mucositis induced by cancer therapies: An overview of systematic reviews","authors":"Huda Anshasi ,&nbsp;Bassema Abufarsakh ,&nbsp;Ja’far M. Alkhawaldeh ,&nbsp;Sura Al Halalmeh","doi":"10.1016/j.ctim.2025.103197","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To synthesize and evaluate the quality of systematic reviews focusing on the use of honey for both the prevention and treatment of oral mucositis induced by cancer therapies.</div></div><div><h3>Methods</h3><div>An overview of systematic reviews was conducted by searching five electronic databases from inception to January 2024 to identify relevant studies evaluating the effectiveness of honey in the prevention and treatment of cancer therapy-induced oral mucositis.</div></div><div><h3>Results</h3><div>Twelve reviews were included, with seven (58.3 %) published after 2018. Five systematic reviews, four of which were rated as high quality, consistently found that honey significantly reduces the occurrence of severe radiation-induced oral mucositis (grades III and IV). Honey may also help alleviate severe pain requiring analgesics and reduce treatment interruptions, particularly among adult patients undergoing radiotherapy. However, findings regarding honey’s effectiveness in reducing the overall incidence of radiation-induced oral mucositis, regardless of severity, were inconsistent. These discrepancies are likely due to variations in patient populations, honey formulations, and timing or duration of administration. Evidence regarding honey's efficacy in chemotherapy- and chemoradiotherapy-induced mucositis remains inconclusive due to methodological limitations, clinical heterogeneity, and a limited number of high-quality studies.</div></div><div><h3>Conclusion</h3><div>Honey may be beneficial in reducing the incidence of severe oral mucositis (grades III and IV), relieving pain, and minimizing treatment disruptions in adult patients undergoing radiotherapy. However, its effectiveness across all grades and treatment modalities remains uncertain due to inconsistent findings, clinical heterogeneity, and methodological limitations. Further high-quality studies are needed to standardize honey types and dosing regimens and to stratify outcomes by mucositis grade, patient age, and cancer therapy type.</div></div><div><h3>Study Registration</h3><div>PROSPERO Protocol registration ID: CRD42024532801</div></div>","PeriodicalId":10545,"journal":{"name":"Complementary therapies in medicine","volume":"92 ","pages":"Article 103197"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Complementary therapies in medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096522992500072X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To synthesize and evaluate the quality of systematic reviews focusing on the use of honey for both the prevention and treatment of oral mucositis induced by cancer therapies.

Methods

An overview of systematic reviews was conducted by searching five electronic databases from inception to January 2024 to identify relevant studies evaluating the effectiveness of honey in the prevention and treatment of cancer therapy-induced oral mucositis.

Results

Twelve reviews were included, with seven (58.3 %) published after 2018. Five systematic reviews, four of which were rated as high quality, consistently found that honey significantly reduces the occurrence of severe radiation-induced oral mucositis (grades III and IV). Honey may also help alleviate severe pain requiring analgesics and reduce treatment interruptions, particularly among adult patients undergoing radiotherapy. However, findings regarding honey’s effectiveness in reducing the overall incidence of radiation-induced oral mucositis, regardless of severity, were inconsistent. These discrepancies are likely due to variations in patient populations, honey formulations, and timing or duration of administration. Evidence regarding honey's efficacy in chemotherapy- and chemoradiotherapy-induced mucositis remains inconclusive due to methodological limitations, clinical heterogeneity, and a limited number of high-quality studies.

Conclusion

Honey may be beneficial in reducing the incidence of severe oral mucositis (grades III and IV), relieving pain, and minimizing treatment disruptions in adult patients undergoing radiotherapy. However, its effectiveness across all grades and treatment modalities remains uncertain due to inconsistent findings, clinical heterogeneity, and methodological limitations. Further high-quality studies are needed to standardize honey types and dosing regimens and to stratify outcomes by mucositis grade, patient age, and cancer therapy type.

Study Registration

PROSPERO Protocol registration ID: CRD42024532801
蜂蜜用于治疗癌症治疗引起的口腔黏膜炎:系统综述
目的对蜂蜜预防和治疗癌症所致口腔黏膜炎的系统综述进行综合评价。方法通过检索5个电子数据库,从建立之初至2024年1月,对评价蜂蜜预防和治疗癌症治疗性口腔黏膜炎有效性的相关研究进行系统综述。结果纳入12篇综述,其中7篇(58.3 %)发表于2018年以后。五项系统评价,其中四项被评为高质量,一致发现蜂蜜显著减少严重辐射引起的口腔黏膜炎的发生(III级和IV级)。蜂蜜还可以帮助缓解需要止痛剂的严重疼痛,减少治疗中断,特别是在接受放射治疗的成年患者中。然而,关于蜂蜜在降低辐射引起的口腔黏膜炎的总体发病率方面的有效性,无论其严重程度如何,研究结果并不一致。这些差异可能是由于患者群体、蜂蜜配方和给药时间或持续时间的差异。关于蜂蜜对化疗和放化疗引起的粘膜炎的疗效的证据,由于方法学的限制、临床异质性和数量有限的高质量研究,仍然没有定论。结论蜂蜜可能有助于降低重度口腔黏膜炎(III级和IV级)的发生率,缓解疼痛,并减少成人放疗患者的治疗中断。然而,由于研究结果不一致、临床异质性和方法学的局限性,其在所有级别和治疗方式中的有效性仍不确定。需要进一步的高质量研究来标准化蜂蜜类型和给药方案,并根据粘膜炎等级、患者年龄和癌症治疗类型对结果进行分层。研究注册普洛斯佩罗协议注册ID: CRD42024532801
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Complementary therapies in medicine
Complementary therapies in medicine 医学-全科医学与补充医学
CiteScore
8.60
自引率
2.80%
发文量
101
审稿时长
112 days
期刊介绍: Complementary Therapies in Medicine is an international, peer-reviewed journal that has considerable appeal to anyone who seeks objective and critical information on complementary therapies or who wishes to deepen their understanding of these approaches. It will be of particular interest to healthcare practitioners including family practitioners, complementary therapists, nurses, and physiotherapists; to academics including social scientists and CAM researchers; to healthcare managers; and to patients. Complementary Therapies in Medicine aims to publish valid, relevant and rigorous research and serious discussion articles with the main purpose of improving healthcare.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信